These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21226632)

  • 21. Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis.
    Sunagawa G; Komiya T; Tamura N; Sakaguchi G; Kobayashi T; Murashita T
    Ann Thorac Surg; 2010 Jun; 89(6):1896-900; discussion 1900. PubMed ID: 20494045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease.
    van Domburg RT; Lemos PA; Takkenberg JJ; Liu TK; van Herwerden LA; Arampatzis CA; Smits PC; Daemen J; Venema AC; Serruys PW; Bogers AJ
    Eur Heart J; 2005 Apr; 26(7):675-81. PubMed ID: 15637087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data.
    Head SJ; Mack MJ; Holmes DR; Mohr FW; Morice MC; Serruys PW; Kappetein AP
    Eur J Cardiothorac Surg; 2012 Mar; 41(3):535-41. PubMed ID: 22219412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PCI versus CABG versus medical therapy in 2006.
    Morrison D
    Minerva Cardioangiol; 2006 Oct; 54(5):643-72. PubMed ID: 17019400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
    Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW;
    J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of age on outcomes of coronary artery bypass surgery compared with balloon angioplasty or bare-metal stent implantation among patients with multivessel coronary disease. A collaborative analysis of individual patient data from 10 randomized trials.
    Flather M; Rhee JW; Boothroyd DB; Boersma E; Brooks MM; Carrié D; Clayton TC; Danchin N; Hamm CW; Hueb WA; King SB; Pocock SJ; Rodriguez AE; Serruys P; Sigwart U; Stables RH; Hlatky MA
    J Am Coll Cardiol; 2012 Nov; 60(21):2150-7. PubMed ID: 23153843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.
    Kapur A; Hall RJ; Malik IS; Qureshi AC; Butts J; de Belder M; Baumbach A; Angelini G; de Belder A; Oldroyd KG; Flather M; Roughton M; Nihoyannopoulos P; Bagger JP; Morgan K; Beatt KJ
    J Am Coll Cardiol; 2010 Feb; 55(5):432-40. PubMed ID: 20117456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognosis of percutaneous coronary intervention and coronary artery bypass grafts for ostial right coronary lesions in propensity-matched individuals.
    Gan HL; Zhang JQ; Huang F; Gu CX; Kong QY; Cao XR; Bo P; Lu CS
    Cardiovasc Ther; 2011 Dec; 29(6):395-403. PubMed ID: 20718758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multivessel percutaneous coronary intervention: a new paradigm for a new century.
    Morrison DA
    Minerva Cardioangiol; 2005 Oct; 53(5):361-77. PubMed ID: 16179881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronary artery bypass graft vs. percutaneous coronary angioplasty: CABG on the rebound?
    Taggart DP
    Curr Opin Cardiol; 2007 Nov; 22(6):517-23. PubMed ID: 17921738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians.
    Rodés-Cabau J; Deblois J; Bertrand OF; Mohammadi S; Courtis J; Larose E; Dagenais F; Déry JP; Mathieu P; Rousseau M; Barbeau G; Baillot R; Gleeton O; Perron J; Nguyen CM; Roy L; Doyle D; De Larochellière R; Bogaty P; Voisine P
    Circulation; 2008 Dec; 118(23):2374-81. PubMed ID: 19029471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of one-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease and acute coronary syndromes (from the CUSTOMIZE Registry).
    Caggegi A; Capodanno D; Capranzano P; Chisari A; Ministeri M; Mangiameli A; Ronsivalle G; Ricca G; Barrano G; Monaco S; Di Salvo ME; Tamburino C
    Am J Cardiol; 2011 Aug; 108(3):355-9. PubMed ID: 21545992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents.
    Banning AP; Westaby S; Morice MC; Kappetein AP; Mohr FW; Berti S; Glauber M; Kellett MA; Kramer RS; Leadley K; Dawkins KD; Serruys PW
    J Am Coll Cardiol; 2010 Mar; 55(11):1067-75. PubMed ID: 20079596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease.
    Yang ZK; Shen WF; Zhang RY; Kong Y; Zhang JS; Hu J; Zhang Q; Ding FH
    J Interv Cardiol; 2007 Feb; 20(1):10-6. PubMed ID: 17300391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
    Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Coronary revascularization of coronary artery disease in patients with diabetes].
    Tsuboi S; Miyauchi K
    Nihon Rinsho; 2011 Feb; 69(2):329-34. PubMed ID: 21387685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial.
    Sobel BE
    Coron Artery Dis; 2010 May; 21(3):189-98. PubMed ID: 20308880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-eluting stent implantation for coronary artery disease: current stents and a comparison with bypass surgery.
    Head SJ; Bogers AJ; Kappetein AP
    Curr Opin Pharmacol; 2012 Apr; 12(2):147-54. PubMed ID: 22285216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current concepts on coronary revascularization in diabetic patients.
    Roffi M; Angiolillo DJ; Kappetein AP
    Eur Heart J; 2011 Nov; 32(22):2748-57. PubMed ID: 21893486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial.
    Morice MC; Serruys PW; Kappetein AP; Feldman TE; Ståhle E; Colombo A; Mack MJ; Holmes DR; Torracca L; van Es GA; Leadley K; Dawkins KD; Mohr F
    Circulation; 2010 Jun; 121(24):2645-53. PubMed ID: 20530001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.